Simplex Trading’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,400
| Closed | -$2K | – | 9935 |
|
|
2024
Q3 | $2K | Sell |
23,400
-27,900
| -54% | -$15.6K | ﹤0.01% | 8113 |
|
|
2024
Q2 | $31K | Sell |
51,300
-92,200
| -64% | -$77.9K | ﹤0.01% | 6551 |
|
|
2024
Q1 | $368K | Buy |
143,500
+62,200
| +77% | +$152K | ﹤0.01% | 4169 |
|
|
2023
Q4 | $165K | Buy |
81,300
+39,200
| +93% | +$71.6K | ﹤0.01% | 4862 |
|
|
2023
Q3 | $72K | Sell |
42,100
-6,200
| -13% | -$11K | ﹤0.01% | 5450 |
|
|
2023
Q2 | $94K | Buy |
48,300
+40,400
| +511% | +$94.6K | ﹤0.01% | 5158 |
|
|
2023
Q1 | $21K | Sell |
7,900
-16,800
| -68% | -$48K | ﹤0.01% | 6891 |
|
|
2022
Q4 | $85K | Buy |
24,700
+16,400
| +198% | +$46.8K | ﹤0.01% | 5276 |
|
|
2022
Q3 | $21K | Sell |
8,300
-44,500
| -84% | -$142K | ﹤0.01% | 7489 |
|
|
2022
Q2 | $127K | Sell |
52,800
-74,800
| -59% | -$196K | ﹤0.01% | 5240 |
|
|
2022
Q1 | $525K | Buy |
127,600
+62,200
| +95% | +$330K | ﹤0.01% | 3785 |
|
|
2021
Q4 | $841K | Buy |
65,400
+39,400
| +152% | +$436K | ﹤0.01% | 3091 |
|
|
2021
Q3 | $235K | Hold |
26,000
| – | – | ﹤0.01% | 5350 |
|
|
2021
Q2 | $237K | Buy |
26,000
+25,891
| +23,753% | +$239K | ﹤0.01% | 5406 |
|
|
2021
Q1 | $102K | Buy |
+109
| New | +$1.5K | ﹤0.01% | 5729 |
|
Simplex Trading's GRTS Position: Q1 2025 in Review
Simplex Trading sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2025, closing a stake of 44,228 shares.
Simplex Trading first reported a position in GRTS in Q4 2021 and held it in 8 quarters. The position peaked at $762K in Q4 2021. 0 funds tracked by Wall St. Rank hold GRTS as of Q1 2025.
- Simplex Trading reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 44,228 Gritstone bio, Inc. Common Stock shares in Q1 2025.
- Simplex Trading first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
- Simplex Trading's Gritstone bio, Inc. Common Stock position peaked at $762K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.